European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
Prognostic value of vestibular-evoked myogenic potentials for disease progression and treatment response in Ménière's disease and endolymphatic hydrops: a systematic review.
СтатьяСистематический обзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Makhoul Mikhael, Ismail Salim, Tawk Dima, Rassam Serena, Deguine Olivier, Marx Mathieu, Legois Quentin
Аннотация
PURPOSE: To evaluate the prognostic and treatment-response value of vestibular-evoked myogenic potentials (VEMPs) in adults with Ménière's disease (MD).
METHODS: A systematic search of MEDLINE, EMBASE, Scopus, and Cochrane Central up to September 2025 was conducted. Longitudinal studies including adults with definite or probable MD, reporting baseline VEMP testing and clinical outcomes (hearing, vertigo, disease progression, or treatment response) were included. Both cervical (cVEMP) and ocular (oVEMP) modalities, including multifrequency protocols, were analyzed. Study quality was assessed using the French version of Newcastle-Ottawa Scale.
RESULTS: Among the initial 415 articles identified, 34 met our inclusion criteria, including 2,422 patients. Abnormal VEMP parameters, including elevated thresholds, increased interaural amplitude ratios, Inter-Frequency Amplitude Ratio, and absent responses, correlated with advanced disease stage, hearing deterioration, vertigo severity, and progression to definite or bilateral MD. VEMP changes were frequently observed following intratympanic gentamicin and select surgical interventions, reflecting treatment response. Multifrequency VEMPs enhanced detection of subclinical otolithic dysfunction and differentiation of active versus stable disease.
CONCLUSION: VEMPs provide a reliable functional biomarker of vestibular involvement, disease progression, and treatment response in MD.
METHODS: A systematic search of MEDLINE, EMBASE, Scopus, and Cochrane Central up to September 2025 was conducted. Longitudinal studies including adults with definite or probable MD, reporting baseline VEMP testing and clinical outcomes (hearing, vertigo, disease progression, or treatment response) were included. Both cervical (cVEMP) and ocular (oVEMP) modalities, including multifrequency protocols, were analyzed. Study quality was assessed using the French version of Newcastle-Ottawa Scale.
RESULTS: Among the initial 415 articles identified, 34 met our inclusion criteria, including 2,422 patients. Abnormal VEMP parameters, including elevated thresholds, increased interaural amplitude ratios, Inter-Frequency Amplitude Ratio, and absent responses, correlated with advanced disease stage, hearing deterioration, vertigo severity, and progression to definite or bilateral MD. VEMP changes were frequently observed following intratympanic gentamicin and select surgical interventions, reflecting treatment response. Multifrequency VEMPs enhanced detection of subclinical otolithic dysfunction and differentiation of active versus stable disease.
CONCLUSION: VEMPs provide a reliable functional biomarker of vestibular involvement, disease progression, and treatment response in MD.